Search results for “Ifn response” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 40 patents, we discovered top 12 key players by total patent application. GlaxoSmithKline Biologicals SA, BioNTech SE, Celldex Therapeutics, Inc. are dominant in this area. They take 65.00% of the total patent filing.
GlaxoSmithKline Biologicals SA
Belgium
Patent: 17
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 4
Celldex Therapeutics, Inc.
New Jersey, United States
Patent: 3
Wyeth LLC
New Jersey, United States
Patent: 2
Xetrios Therapeutics, Inc.
California, United States
Patent: 2
BioNTech RNA Pharmaceuticals GmbH
Rheinland-Pfalz, Germany
Patent: 2
Toray Industries, Inc.
Tokyo-to, Japan
Patent: 1
Riken Corp.
Tokyo-to, Japan
Patent: 1
Aeras Global TB Vaccine Foundation
United States
Patent: 1
Debiotech SA
Vaud, Switzerland
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 9 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing TRON - Translationale Onkologie an der Universitätsmedizin der, BioNTech SE, BioNTech RNA Pharmaceuticals GmbH take 122.22% of patent filing during this period.
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 5
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 4
BioNTech RNA Pharmaceuticals GmbH
Rheinland-Pfalz, Germany
Patent: 2
St. Jude Children's Research Hospital, Inc.
Tennessee, United States
Patent: 1
Debiotech SA
Vaud, Switzerland
Patent: 1
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 9 patents in last 5 years, we discover 4 new entrants. TRON - Translationale Onkologie an der Universitätsmedizin der, BioNTech SE, BioNTech RNA Pharmaceuticals GmbH are the most active new entrants in this area.
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 5
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 4
BioNTech RNA Pharmaceuticals GmbH
Rheinland-Pfalz, Germany
Patent: 2
Debiotech SA
Vaud, Switzerland
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 60 patents, we discovered top 8 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, The Salk Institute for Biological Studies, University of Kentucky are dominant in this area. They take 108.33% of the total patent filing.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 46
The Salk Institute for Biological Studies
California, United States
Patent: 4
University of Kentucky
Kentucky, United States
Patent: 3
University of Bonn
Nordrhein-Westfalen, Germany
Patent: 3
The Rockefeller University
New York, United States
Patent: 2
University of Basel
Basel-Stadt, Switzerland
Patent: 2
Hiroshima University
Hiroshima-ken, Japan
Patent: 1
University of Massachusetts Medical School
Massachusetts, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: